(MedPage Today) — The first FDA-approved treatment option for Sjögren’s disease might be on the horizon, as neonatal Fc receptor (FcRn) blockers show promise in early data.
B-cell activation in Sjögren’s disease results in immunoglobulin…
Source link : https://www.medpagetoday.com/spotlight/acr-sjogrens-syndrome/119151
Author :
Publish date : 2025-12-23 13:49:00
Copyright for syndicated content belongs to the linked Source.
